MedPath

Seoul National University

Seoul National University logo
🇰🇷South Korea
Ownership
Private
Established
1946-08-22
Employees
5K
Market Cap
-
Website
http://www.snu.ac.kr

Clinical Trials

101

Active:4
Completed:57

Trial Phases

2 Phases

Phase 3:1
Not Applicable:95

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (96 trials with phase data)• Click on a phase to view related trials

Not Applicable
95 (99.0%)
Phase 3
1 (1.0%)

Impact of Concomitant Use of Steroids and Immune-Checkpoint Inhibitors on Survival Outcomes in NSCLC Patients

Active, not recruiting
Conditions
NSCLC, Non Small Cell Lung Cancer
Interventions
Drug: Corticosteroids (CS)
Drug: Immune Checkpoint Inhibitors
First Posted Date
2024-12-27
Last Posted Date
2024-12-27
Lead Sponsor
Seoul National University
Target Recruit Count
2000
Registration Number
NCT06751108
Locations
🇰🇷

Seoul National University, Seoul, Korea, Republic of

Effectiveness and Implementation of Mobile Health Platform for Medication Management and E-Labeling (eDrugSafe)

Not Applicable
Recruiting
Conditions
Mobile Health
Medication Management
Drug Labelling
First Posted Date
2024-11-25
Last Posted Date
2024-11-27
Lead Sponsor
Seoul National University
Target Recruit Count
360
Registration Number
NCT06703697
Locations
🇰🇷

Seoul National University, Seoul, Gwanak-gu, Korea, Republic of

Thoracic Sympathetic Ganglion Block With Botulinum Toxin Type A

Not Applicable
Not yet recruiting
Conditions
Complex Regional Pain Syndromes
Interventions
First Posted Date
2024-06-24
Last Posted Date
2024-06-26
Lead Sponsor
Seoul National University
Target Recruit Count
78
Registration Number
NCT06470581

The Comparison of Sympathetic Blockade of Stellate Ganglion Block and Thoracic Sympathetic Ganglion Block

Not Applicable
Not yet recruiting
Conditions
Complex Regional Pain Syndromes
Post Herpetic Neuralgia
Chronic Pain
Neuropathic Pain
Post Laminectomy Syndrome
First Posted Date
2023-11-14
Last Posted Date
2024-05-29
Lead Sponsor
Seoul National University
Target Recruit Count
118
Registration Number
NCT06130514

Spatially Transcriptomics Reveals Molecular Signatures in CRPS

Recruiting
Conditions
Complex Regional Pain Syndromes
First Posted Date
2023-08-14
Last Posted Date
2024-05-29
Lead Sponsor
Seoul National University
Target Recruit Count
10
Registration Number
NCT05986461
Locations
🇰🇷

Seoul National University Hospital, Seoul, Korea, Republic of

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next

News

No news found
© Copyright 2025. All Rights Reserved by MedPath